LBA16RAMUCIRUMAB (RAM) AS SECOND-LINE TREATMENT IN PATIENTS...

Annals of Oncology 2014 / 09 Vol. 25; Iss. suppl_4

LBA16RAMUCIRUMAB (RAM) AS SECOND-LINE TREATMENT IN PATIENTS (PTS) WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC) FOLLOWING FIRST-LINE THERAPY WITH SORAFENIB: RESULTS FROM THE RANDOMIZED PHASE III REACH STUDY

Zhu, A.X., Ryoo, B.Y., Yen, C.J., Kudo, M., Poon, R., Pastorelli, D., Blanc, J-F., Chung, H.C., Baron, A.D., Pfiffer, T.E.F., Okusaka, T., Kubackova, K., Trojan, J., Sastre, J., Chau, I., Chang, S-C.,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
25
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu438.16
Date:
September, 2014
File:
PDF, 36 KB
english, 2014
Conversion to is in progress
Conversion to is failed